Gilead Sciences And Zydus Launch SoviHep Hepatitis C Drug Zydus and Gilead Sciences bring Hepatitis C drug SoviHep to India. Between 150 million and 200 million people across the world suffer from Hepatitis C. by Sumit Passary
Healthy Living/Wellness FDA approves Gilead's Harvoni drug: Can we afford the $1125 once-a-day Hepatitis C pill? by Aaron Mamiit
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband